Complement activation in patients with COVID-19: A novel therapeutic target - 22/07/20
Doi : 10.1016/j.jaci.2020.05.006
Massimo Cugno, MD a, b 
, Pier Luigi Meroni, MD c, Roberta Gualtierotti, MD a, b, Samantha Griffini, PhD a, b, Elena Grovetti, BSc a, b, Adriana Torri, MD b, Mauro Panigada, MD d, e, Stefano Aliberti, MD a, e, Francesco Blasi, MD a, e, Francesco Tedesco, MD c, Flora Peyvandi, MD a, b
, Pier Luigi Meroni, MD c, Roberta Gualtierotti, MD a, b, Samantha Griffini, PhD a, b, Elena Grovetti, BSc a, b, Adriana Torri, MD b, Mauro Panigada, MD d, e, Stefano Aliberti, MD a, e, Francesco Blasi, MD a, e, Francesco Tedesco, MD c, Flora Peyvandi, MD a, b a Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
b Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy
c Immunorheumatology Research Laboratory, IRCCS Istituto Auxologico Italiano, Milan, Italy
d Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, UOC Anestesia e Terapia Intensiva Adulti, Milan, Italy
e Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, UOC Pneumologia, Milan, Italy
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2020
American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 146 - N° 1
P. 215-217 - juillet 2020 Regresar al número
Artículo precedente
- Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
- Emanuele Pontali, Stefano Volpi, Giancarlo Antonucci, Marco Castellaneta, Davide Buzzi, Francesca Tricerri, Alessia Angelelli, Roberta Caorsi, Marcello Feasi, Francesca Calautti, Elio Castagnola, Gian Andrea Rollandi, Angelo Ravelli, Giovanni Cassola, Marco Gattorno
- COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab
- Ulrike Förster-Ruhrmann, Agnieszka J. Szczepek, Claus Bachert, Heidi Olze
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.